Researchers at Texas A&M University published a study in Translational Psychiatry identifying time-specific patterns of brain activity following a single ketamine infusion in older adults aged 55 and older with treatment-resistant depression. Led by Sanjay Mathew, the team mapped how information sharing across the brain shifts over hours and days.
In Plain English: The Clinical Takeaway
- Beyond the Initial Infusion: Ketamine’s antidepressant effects do not fade immediately when the brief drug exposure ends; instead, brain connectivity continues to reorganize over a seven-day window.
- Measuring Malleability: Rather than looking at single brain signals, researchers used advanced information-theory models to track how multiple regions coordinate and share information.
- Predicting Patient Response: Greater increases in brain-wide information sharing measured 24 hours post-infusion correlated directly with reduced depressive symptoms by Day 7.
Mapping the Aging Brain Post-Infusion
Ketamine has emerged as a rapid-acting intervention for patients whose depression has failed to respond to standard pharmacological regimens. Yet, translating these therapies to geriatric populations has historically lagged due to legitimate clinical concerns regarding safety, efficacy, and underlying aging pathology in the central nervous system.
To evaluate these physiological responses, researchers within the Experimental Psychopharmacology of Mood and Anxiety Disorders Lab (EPMAD Lab) at Texas A&M studied U.S. veterans over the age of 55. Nicholas Murphy, research associate professor in the Department of Psychiatry and Behavioral Sciences, coordinates the neuroscience-informed treatments wing of the lab. He uses an accessible metaphor to describe the drug’s mechanism of action—the physiological cascade triggered when the drug alters glutamate transmission.
“Let’s say you had a map of rivers in the desert,” Murphy explained. “You release the dam, and now all the tributaries are being flooded with water. We now have these connections between places, and that’s what ketamine does; it helps to create a more flexible and densely connected environment. But this isn’t the end of the story. For it to be useful, we need to understand how that water is flowing, and that’s where our current analysis comes in. It tells us how the surging of glutamate released by ketamine needs to flow to get a clinical response.”
Advanced EEG Analysis and High-Order Interactions
The multi-institutional team—collaborating with researchers at Baylor College of Medicine and the University of the Balearic Islands—sought to understand how information organization changes dynamically over time following a single ketamine infusion.
Krisha Shah, a research associate in the department, highlighted the limitations of conventional electroencephalography (EEG) evaluations. “Often, EEG research looks at individual brain signals or communication between pairs of signals, but the brain doesn’t operate in pairs. It’s a highly interconnected system,” she noted. “Ketamine is unusual because the drug exposure is brief, but antidepressant effects have the potential to extend well beyond that experience.”
To capture this scale of complexity, the research team utilized high-order interactions. This information-theory approach examines how data is organized across multiple EEG signals simultaneously. The findings confirmed that ketamine does not trigger a static, singular pattern of neural activity. Instead, distinct connectivity configurations emerge at one hour, 24 hours, and seven days post-treatment. Crucially, heightened information sharing at the 24-hour mark served as a robust biological indicator for symptom improvement at Day 7.
| Research Parameter | Observed Finding / Methodology |
|---|---|
| Target Demographic | U.S. veterans aged 55 and older with treatment-resistant depression |
| Intervention | Single ketamine infusion |
| Analytical Framework | High-order interactions via EEG to evaluate multi-signal neural coordination |
| Key Temporal Milestones | Distinct network configurations identified at 1 hour, 24 hours, and 7 days post-infusion |
| Predictive Biomarker | Increased information sharing at 24 hours correlated with symptom reduction at Day 7 |
Bridging Geriatric Care Gaps and Future Therapeutics
Most drug studies routinely restrict enrollment to individuals under age 65, leaving a significant evidence gap regarding how neuroactive compounds interact with aging neural architecture. Older adults comprise over a third of the population, yet they remain underrepresented in clinical research.
This latest study builds directly upon two preceding publications from the Texas A&M group establishing that intravenous ketamine administration is both feasible and clinically effective in older demographics. By charting the temporal evolution of brain connectivity, the team has taken a vital step toward establishing clinically reliable biomarkers for late-life depression management.
“Ketamine has come a long way from its humble beginnings as an anesthetic,” Murphy stated. “However, it still has a strong abuse potential. The goal of the work that my team has been doing is to identify these key points in that physiological roadmap so it can be acted upon via another mechanism that doesn’t have the psychedelic or medical side effects of ketamine.”
Contraindications & When to Consult a Doctor
References
- Shah, K., et al. Time-specific patterns of brain activity following ketamine treatment in older adults with treatment-resistant depression. Translational Psychiatry.
- Experimental Psychopharmacology of Mood and Anxiety Disorders Lab (EPMAD Lab), Texas A&M University.
- Baylor College of Medicine & University of the Balearic Islands collaborative EEG research archives.
